 | The topic of this article may not meet Wikipedia's general notability guideline .(September 2023) |
 | This article needs additional citations for verification .(September 2023) |
| Formerly | Avecia Biotechnology Inc. (2001–2012) |
|---|---|
| Company type | Subsidiary |
| Industry | Biotechnology |
| Defunct | 15 September 2015  |
| Headquarters | Milford, Massachusetts, U.S. |
| Parent | Nitto Denko Corporation |
Avecia, a part of Nitto Denko Inc., is a private biotechnology company focused on oligonucleotide production. [1] Avecia has two facilities, one near Boston, MA, and the second in Cincinnati, OH. [1] In 2016 Avecia acquired the assets of Irvine Pharmaceutical Services and Avrio Biopharmaceuticals. [2] Avecia was organized with a biologics business line and the oligonucleotide business line. In 2009, Avecia Biologics Limited based in Billingham, UK was acquired by Merck and was later part of Fujifilm Diosynth Biotechnologies. [3]